南洋行家论股
IHH医疗保健 进中成本拉低财测
目标价：7令吉
最新进展：
IHH医疗保健集团（IHH，5225，主板贸服股）截至3月底首季，净利5723万5000令吉，暴跌87.82%。
营业额则微增6.34%，报28亿5495万3000令吉。
行家建议：
由于现金余额出现汇兑亏损1.04亿令吉，拖累IHH医疗保健首季核心盈利，比我们和市场财测低12%至13%。若扣除汇兑亏损，核心盈利则符合预期。
在考虑到中国初期运作成本增加，我们把2018至2020财年每股盈利预测调降2%。
不过，该集团的发展计划保持不变，所以我们维持“买入”，以及目标价格7令吉。
所有本土市场，包括新加坡、大马、土耳其和印度，继续表现稳定，而新的香港鹰阁医院的表现则继续改善及收窄亏损。
香港鹰阁医院首季入住率提高到40%至45%，也在4、5月继续攀升。
若是购得印度富通股权，IHH医疗保健有信心可取得长期协同效应，且在未来18至24个月扭转业务表现。
http://www.enanyang.my/news/20180531/ihh医疗保健br-进中成本拉低财测/
Related Stocks
| Chart | Stock Name | Last | Change | Volume |
|---|
Market Buzz
2024-10-04
IHH2024-10-04
IHH2024-10-04
IHH2024-10-04
IHH2024-10-04
IHH2024-10-03
IHH2024-10-03
IHH2024-10-03
IHH2024-10-02
IHH2024-10-02
IHH2024-10-02
IHH2024-10-02
IHH2024-10-02
IHH2024-10-01
IHH2024-10-01
IHH2024-10-01
IHH2024-09-30
IHH2024-09-30
IHH2024-09-30
IHH2024-09-30
IHH2024-09-27
IHH2024-09-27
IHH2024-09-26
IHH2024-09-26
IHH2024-09-26
IHH2024-09-26
IHH2024-09-26
IHH2024-09-26
IHH2024-09-26
IHH2024-09-25
IHH2024-09-24
IHH2024-09-24
IHHMore articles on 南洋行家论股
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
Introducing MY's First IPO Fund for Sophisticated Investors!
New Update. Discover investment communities that resonate with your ideas
M & A Value Partners IPO Equity Fund has been launched - Targeted 13% Return p.a
Latest Videos
Apps
Top Articles
1
BFM Podcast
3
BFM Podcast
4
BFM Podcast
5
6
7
BFM Podcast
8
BFM Podcast
#
Stock
Score
Daily Stocks
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
